Hyperthyroidism is the most common endocrine disease of senior cats and affects roughly 10% of cats older than 10 years. It is characterized by excessive production of thyroid hormone, especially T4. If left untreated, it may lead to cardiomyopathy, hypertension, unmasking of CKD, and death. Treatment options include antithyroid medication such as methimazole, surgery, radioactive iodine (I-131), and an iodine-restricted diet such as Hill's y/d. This article reviews the pathophysiology, clinical signs, diagnostic methods, treatment choices, and nutrition-based management of feline hyperthyroidism.
Signs That Warrant Veterinary Examination
- Weight loss despite a normal or increased appetite
- Polyphagia — the cat seems ravenously hungry
- Hyperactivity and restlessness in an older cat
- Polyuria/polydipsia — drinking and urinating more
- Vomiting and diarrhea related to increased GI motility
- Poor coat quality — dull coat, matting, or excessive shedding
- Tachycardia — heart rate greater than 220/min
- Behavioral change — irritability, aggression, or nighttime vocalization
1. Pathophysiology
About 97-99% of cases are caused by benign adenoma or adenomatous hyperplasia. Only 1-3% are thyroid carcinoma. Roughly 70% involve both thyroid lobes. These adenomas produce T4 autonomously despite TSH suppression.
Excess T4 causes an increase in basal metabolic rate, driving calorie expenditure higher and causing weight loss despite increased appetite. Protein catabolism contributes to muscle loss. GI motility increases, leading to diarrhea or vomiting. Sympathetic tone rises, promoting tachycardia and restlessness.
Chronic T4 excess may produce a hypertrophic cardiomyopathy-like phenotype with left ventricular thickening, tachycardia, gallop rhythm, and systolic murmur. Systemic hypertension occurs in some cats. The cardiac changes may be partly reversible with treatment, which is why early diagnosis matters.
2. Hyperthyroidism and CKD — A Critical Connection
The CKD Masking Effect
Hyperthyroidism increases renal blood flow and GFR, which can mask concurrent CKD:
- Creatinine may appear misleadingly low in a hyperthyroid cat because GFR is increased
- Once hyperthyroidism is treated, GFR falls and creatinine may rise, revealing CKD
- That is why SDMA should be reviewed before treatment, since it is less dependent on GFR alone
- Kidney values must be rechecked during the first weeks of methimazole treatment
- If significant CKD becomes apparent, methimazole dosing may need adjustment — a balanced approach is essential
3. Diagnosis
| Test | Finding | Clinical Note |
|---|---|---|
| Serum Total T4 | High, often above 4.0 µg/dL | Primary screening test; elevated in most cases, but early or mild disease may still test in the reference range |
| Free T4 (fT4) | High | Useful if Total T4 is borderline but suspicion remains high; not diagnostic on its own because false positives occur |
| TSH | Suppressed | Low TSH plus high T4 is supportive, especially in early cases |
| Neck palpation | Palpable thyroid nodule | Experienced clinicians detect enlargement in many cases, but a negative palpation does not rule disease out |
| Cardiac assessment | Tachycardia, murmur, gallop | ECG and echocardiography may be needed to assess cardiac effects |
| Blood pressure | Systolic pressure above 160 mmHg | Hypertension screening is important because of retinal and renal risk |
| Kidney panel | Creatinine, BUN, SDMA, urinalysis | Essential for evaluating masked CKD before treatment |
| Thyroid scintigraphy | Functional thyroid imaging | Gold standard for bilateral disease, ectopic tissue, and planning surgery or I-131 |
Occult Hyperthyroidism
Some hyperthyroid cats have Total T4 results in the high-normal range. This may occur in early disease or when another illness suppresses T4 values. If clinical suspicion is strong but Total T4 is not overtly elevated, repeat testing, fT4 measurement, or TSH assessment may be appropriate.
4. Treatment Options
| Treatment | Mechanism | Advantages | Limitations |
|---|---|---|---|
| Methimazole | Antithyroid drug that inhibits thyroid hormone synthesis | Widely available, adjustable, reversible, and relatively affordable | Requires lifelong dosing; adverse effects may include GI signs, facial pruritus, cytopenias, and rarely hepatotoxicity |
| Transdermal methimazole | Gel applied to the inner pinna | Helpful when oral dosing is difficult | Absorption may be variable; dose adjustment can be harder; dermatitis can occur |
| Radioactive iodine (I-131) | Selectively destroys hyperfunctional thyroid tissue | Gold standard and often curative; usually one treatment; very high success rate | Requires a referral facility, radiation isolation, and relatively high upfront cost |
| Thyroidectomy | Surgical removal of thyroid tissue | Potentially curative in one procedure | Anesthetic risk in older cats, risk of hypocalcemia, hypothyroidism, and recurrent laryngeal nerve injury |
| Iodine-restricted diet | Limits T4 production by severely restricting iodine intake | Noninvasive and practical in selected households | The cat must eat only this diet; otherwise efficacy is lost |
4.1 Methimazole Treatment Protocol
Methimazole Initiation and Monitoring
Starting Phase
- Dose: typically 1.25-2.5 mg PO BID
- Start low whenever possible
- Felimazole is a common tablet option
- Transdermal formulations may be used in selected cats
Recheck at 2-4 Weeks
- Reassess T4
- Repeat CBC and chemistry
- Recheck kidney values carefully
- Adjust the dose if needed
Stable Phase
- Target T4 is generally low-normal to mid-normal
- Recheck T4 and kidney status every 3-6 months
- Repeat CBC periodically
- Monitor blood pressure over time
4.2 Methimazole Adverse Effects
| Adverse Effect | Frequency | Management |
|---|---|---|
| GI signs such as vomiting, anorexia, diarrhea | Most often in the first weeks | May be transient; giving with food or lowering the dose may help |
| Facial pruritus or excoriation | Uncommon but important | Usually requires stopping the drug and selecting another strategy |
| Leukopenia or thrombocytopenia | Uncommon | Monitor CBC and discontinue if clinically significant |
| Hepatotoxicity | Rare but serious | Monitor liver enzymes; stop immediately if jaundice develops |
| Overtreatment causing hypothyroidism | Dose dependent | Reduce the dose if T4 becomes too low, especially because it may worsen CKD recognition |
5. Nutritional Management — The VetKriter Approach
VetKriter Nutrition Principle
Nutrition in hyperthyroid cats has two dimensions: first, an iodine-restricted diet may be used as a treatment strategy in selected cases; second, cats treated with medication, surgery, or I-131 often need nutritional support to restore body weight and muscle mass. Concurrent CKD complicates dietary decisions, so plans must be individualized.
5.1 Iodine-Restricted Diet (Hill's y/d)
- Noninvasive: no pills, surgery, or radiation required
- Effective in some cats: T4 may normalize within a few weeks
- Useful when owners cannot medicate reliably
- Lower drug-related adverse effect burden
- Available in wet and dry forms
- Single-diet rule: the cat must eat only this food
- Multi-cat households: controlling access can be difficult
- Outdoor cats: hunting or eating elsewhere makes control hard
- Nutritional debate: long-term implications of severe iodine restriction remain debated
- Severe disease: may not be sufficient on its own when T4 is very high
The Absolute Rule with y/d
For an iodine-restricted diet to work, the cat must eat only that diet. Even small amounts of tuna, treats, or another cat’s food can increase iodine intake enough to undermine treatment. This option should therefore be considered carefully in multi-cat households, outdoor cats, and highly selective eaters.
5.2 General Nutritional Strategy in the Hyperthyroid Cat
| Situation | Nutritional Approach |
|---|---|
| Weight loss / muscle wasting | Higher-protein, calorie-dense foods; small frequent meals; wet food often helps; aim to restore lean mass |
| Concurrent CKD | Diet selection is complex because renal priorities may conflict with the need for more protein; an individualized compromise is often needed |
| GI signs | Highly digestible diets, smaller portions, and consideration of GI-support strategies |
| Methimazole-related inappetence | Warm the food, rotate acceptable flavors, give the drug with food when appropriate, and consider appetite support if needed |
| Post-treatment normalization | Once T4 stabilizes, track weight regain and prevent rebound obesity through calorie adjustment |
5.3 Nutritional Support Components
| Component | Function | Clinical Note |
|---|---|---|
| High-quality protein | Supports recovery from muscle loss and negative nitrogen balance | Prefer highly digestible animal protein sources |
| Omega-3 (EPA/DHA) | Anti-inflammatory effects, cardiac support, and possible renal support | Especially useful when hyperthyroidism and CKD coexist |
| L-carnitine | Fatty-acid metabolism, energy production, and cardiac support | Potentially useful in hypermetabolic patients |
| Taurine | Essential for cardiac function and mandatory in feline nutrition | Particularly important when cardiomyopathy is present |
| Antioxidants (E, C, Se) | Reduce oxidative stress related to excess thyroid hormone activity | Mixed tocopherols and well-formulated selenium sources are preferred |
| B vitamins | Support energy metabolism under hypermetabolic conditions | Requirements may increase when metabolism is accelerated |
6. Choosing a Treatment — Decision Algorithm
Key Factors That Influence Treatment Choice
- CKD status: concurrent CKD often makes an adjustable option like methimazole attractive
- Age: very old cats may be managed medically; younger seniors may be better candidates for I-131 or surgery
- Disease severity: severe T4 excess may need medical stabilization before a curative plan
- Cardiac status: HCM increases anesthetic risk and changes decision-making
- Owner compliance: inability to give daily medication may shift the balance toward diet or definitive treatment
- Multi-cat household: difficult dietary control may make y/d unsuitable
- Cost structure: medication accumulates over time, whereas I-131 or surgery has a high one-time cost
- Access: radioactive iodine may not be widely available; surgery requires an experienced surgeon
7. Iodine and Environmental Factors
Why Has Hyperthyroidism Become So Common?
The prevalence of feline hyperthyroidism has increased dramatically over recent decades. Proposed contributors include variation in dietary iodine content, exposure to endocrine disruptors such as BPA and PBDEs, greater longevity of pet cats, and better diagnostic awareness. The true cause is likely multifactorial and remains incompletely defined.
8. Home Monitoring and Follow-Up
- Weight: weekly weighing; gain after treatment is usually a good sign
- Appetite: record daily food intake
- Water intake: watch for changes in polydipsia
- Activity: reduced hyperactivity may indicate treatment response
- Heart rate: coarse assessment at home may be helpful in some cats
- Coat quality: improvement often becomes visible over several weeks
- Medication compliance: maintain a daily dosing record
- First month: T4, kidney panel, and CBC at 2-4 weeks
- After stabilization: T4 plus creatinine/SDMA every 3-6 months
- Every 6 months: full blood work, urinalysis, and blood pressure
- Annually: echocardiography if cardiac disease is a concern
- Urgent recheck: vomiting, anorexia, or jaundice may indicate methimazole toxicity
9. Prognosis
- Well-managed methimazole therapy: many cats maintain a normal life expectancy, but lifelong treatment is required
- I-131: very high success rate and often curative
- Surgery: can be successful in experienced hands with acceptable complication control
- Concurrent CKD: makes prognosis more complex and requires balance
- Thyroid carcinoma: uncommon, but prognosis is more variable and treatment intensity is higher
- Untreated disease: progressive weight loss, cardiomyopathy, kidney compromise, and death
10. References
- Peterson ME. Hyperthyroidism in cats: what's causing this epidemic of thyroid disease and can we prevent it? JVIM. 2012;26(5):963-975.
- Carney HC, et al. AAFP Guidelines for the Management of Feline Hyperthyroidism. JFMS. 2016;18(5):400-416.
- Trepanier LA. Pharmacologic management of feline hyperthyroidism. Vet Clin North Am Small Anim Pract. 2007;37(4):775-788.
- van der Kooij M, et al. Effects of an iodine-restricted food on client-owned cats with hyperthyroidism. JFMS. 2014;16(6):491-498.
- Edinboro CH, et al. Epidemiologic study of relationships between consumption of commercial canned food and risk of hyperthyroidism in cats. JAVMA. 2004;224(6):879-886.
- Wakeling J, et al. Diagnosis of hyperthyroidism in cats with mild chronic kidney disease. JVIM. 2008;22(5):1055-1060.
- IRIS — International Renal Interest Society. CKD Staging Guidelines (modified 2023).
- WSAVA Global Nutrition Committee. Nutritional Assessment Guidelines. 2024.